New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2014
08:56 EDTANIPANI Pharmaceuticals 1.4M share Spot Secondary priced at $31.00
Oppenheimer and Roth Capital acted as joint book running managers for the offering.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 1, 2016
08:13 EDTANIPANI acquires exclusive rights to distribute three generics from H2 Pharma
ANI Pharmaceuticals announced that it has acquired the exclusive rights to distribute 1% and 2.5% hydrocortisone cream for rectal use and the exclusive rights to distribute the authorized generic of Lipofen from H2-Pharma, LLC for $10M. In addition, ANI also acquired an early stage development project for an undisclosed generic injectable drug product.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use